A mixed-methods study developed usable information leaflets but did not test whether they reduced benzodiazepine use.
Older consumers, carers, and hospital professionals reviewed and tested leaflets over several rounds. For the benzodiazepine/Z-drug leaflet, consumers generally located and understood the tested information, and professionals reported high usability. The process identified practical improvements in presentation and wording.
Participants were not a randomized group undergoing a measured taper, and the study did not establish discontinuation rates, withdrawal safety, or sustained sleep outcomes. Consumer recruitment and small testing groups also limit generalization. The authors called for evaluation in clinical transitions of care. The leaflet is therefore evidence about communication design, rather than proof that education alone produces safe deprescribing. In an individual matter, receiving written information, understanding it, and successfully changing medication are separate events that should be documented separately.
Original analysis of the supplied journal article, identified as PMC6924866.